Reports on engineered bacterial therapeutics for tumor.
Chassis | Target disease | Genetically encoded biosensor | Actuator | Model | Refs |
---|---|---|---|---|---|
Tumor | - | α-hemolysin | BALB/c mice | [36] | |
Tumor | - | Type 3 secretion system Mitochondrial targeting domain of Noxa |
BALB/c mice | [37] | |
Tumor | - | Cyclic di-AMP | C57BL/6 mice BALB/c mice |
[38] | |
Tumor | - | L-Arginine | C57BL/6 mice | [39] | |
Tumor | - | Melanine | BALB/c mice | [40] | |
Colorectal cancer | - | P8 | BALB/c mice C57BL/6J mice |
[42] | |
Colorectal cancer | Lactate, pH, Hypoxia-inducible sensor for the expression of serine integrase | Hemolysin | BALB/c mice C57BL/6J mice |
[43] | |
Colorectal cancer | - | INP-tagged histone-like protein A YebF-fused I1 myrosinase |
BALB/c mice | [44] | |
Head and neck squamous cell carcinoma | - | MDA-7/IL-24 | BALB/c mice | [49] | |
Tumor | AHL-inducible sensor for the production of transcription factor and lysis protein | Phage-lysis protein (ϕX174E) HA-tagged CD47 antagonistic nanobody |
BALB/c mice C57BL/6 mice |
[50] | |
Tumor | Phage-lysis protein (ϕX174E) HA-tagged PD-L1 blocking nanobody HA-tagged CTLA4 blocking nanobody Granulocyte-macrophage colony-stimulation factor |
BALB/c mice | [51] | ||
Colorectal neoplasia | C57BL/6 mice | [52] |